New treatment options
ZAT Company an use a proprietary method to extend the treatment of MDM, decided by the European certification company DNV.
The classification society DNV has verified and approved by Pribram ZAT expansion of treatment using the MDM (mesodiencefalická modulation) for other complications of diseases associated with poor tissue perfusion, such as migraine, arthritis, high blood pressure, ulcer disease, etc. (see attachment).
MDM method is particularly suitable in cases of resistance to treatment when ill and doctors are under severe pressure unbearable influence the patient's discomfort, with intolerance or allergic reactions to pharmaceutical preparations such as support for the effect of standard therapy, in which significantly reduces the treatment time, etc. The method has No side effects. By extending the use of physical methods MDM opens the possibility of using the wide potential of this new technology in medicine for the treatment of EU citizens.
The only manufacturer in the world with exclusive rights to the patent, the company Pribram ZAT
CURRENT METHODS OF USE FOR TREATMENT OF DIABETES
Currently, the method MDM early as 3 year has been used successfully to treat complications of diabetes - diabetic neuropathy, in which medication treatment is almost ineffective.
In the Central Region has over 70 thousand registered diabetic patients, of whom over half have suffered this most common complication of diabetes. They can undergo treatment in MDM Center in Pribram.
